TAGLN2 and cancer: LMO2 (175), MSN (176), TAGLN2 (177), SRSF3 (178), SAFB (179), SIN3A (180), TRIM24 (181) and AUTS2 (182) appears to be constitutively activated in cancer, but these genes might be novel target for obesity.